Skip to main contentaccessibility options
PRINT | BOOKMARK | TEXT SIZE A A A

About TMRI

Scotland has strong claims to be a major centre for Translational Medicine as a result of its internationally competitive clinical academic research base, renowned high quality teaching hospitals, state of the art clinical research facilities and advanced patient databases.

TMRI was established in April 2006 to capitalise on these strengths, creating an industry access point and execution vehicle for large-scale collaborations and projects based on the significant Translational Medicine expertise that resides in Scotland.

TMRI is a private limited company focused on commercial interactions with industry-leading partners towards valuable commercial outputs. The Company is owned by Scottish Enterprise, the Universities of Aberdeen, Dundee, Edinburgh and Glasgow and their associated NHS Health Boards.

TMRI is the principal delivery and exploitation vehicle for the Scottish Translational Medicine Research Collaboration (TMRC), an ambitious and unique venture that brings together Wyeth Pharmaceuticals with TMRI’s shareholder partners. TMRI will deliver and manage £50m of research funding for TMRC projects.